Cardiomyocyte STIM1 downregulation exacerbates post-Myocardial Infarction remodeling by dysregulating mitochondrial

Insights

Decreased stromal interaction molecule 1 (STIM1) in cardiomyocytes worsens heart remodeling after injury. This occurs through altered mitochondrial function and metabolism, impacting cardiac electrophysiology.

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Biology
  • Cardiac Electrophysiology

Background:

  • Stromal interaction molecule 1 (STIM1) loss in smooth muscle cells protects against ischemia-reperfusion (I/R) injury.
  • The role of STIM1 in cardiomyocytes (CM) during I/R injury and cardiac remodeling is unknown.

Purpose of the Study:

  • To investigate how reduced CM-STIM1 expression affects cardiac function before and after I/R injury.
  • To elucidate the mechanisms underlying STIM1's role in cardiac remodeling and electrophysiology post-I/R.

Main Methods:

  • Adeno-associated virus 9 (AAV9) mediated shRNA delivery to knockdown STIM1 in mouse cardiomyocytes.
  • Induction of myocardial infarction (MI) via coronary artery occlusion in vivo.
  • Assessment of cardiac mechanical, structural, electrophysiological, metabolic, and mitochondrial properties.

Main Results:

  • Reduced CM-STIM1 expression exacerbated post-MI left ventricular dysfunction, structural remodeling, and fibrosis.
  • Knockdown of STIM1 in CMs led to smaller, rounded mitochondria with increased pDRP1 and reduced OPA1, impacting AMPK signaling and fatty acid oxidation.
  • STIM1 deficiency predisposed hearts to spatially-discordant action potential alternans and pro-arrhythmic vulnerability.

Conclusions:

  • Decreased CM-STIM1 expression worsens post-MI cardiac remodeling by disrupting mitochondrial dynamics and metabolic processes.
  • STIM1-dependent mitochondrial alterations impair cardiac electrophysiological function, particularly under stress conditions like elevated heart rate, independent of MI.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...